Large-scale testing (Phase 3)Study completedNCT04629703
What this trial is testing
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)SARS Pneumonia+3 more
Rigel Pharmaceuticals 280